Shionogi’s COVID Pill Might Not Be Applicable for Emergency Approval: JPMA Exec

JPMA Senior Managing Director Kazuhiko Mori Kazuhiko Mori, senior managing director of the Japan Pharmaceutical Manufacturers Association (JPMA), said on September 15 that Shionogi’s oral pill and KM Biologics’ jab for COVID-19 do not seem to qualify for the newly...read more